As featured in…
Latest Press Releases
BIOLIFE4D CSO Dr. Ravi Birla Publishes Paper in Prestigious APL Bioengineering Scholarly Journal
Birla co-published paper with Stuart K. Williams, a renowned industry figure, to highlight 3D bioprinting’s impact on cardiac failure treatment CHICAGO – February 27, 2020 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced its Chief Science Officer, Dr. Ravi Birla, has published a paper…
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
Company surpasses $3M in accepted investments CHICAGO – September 16, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced it has modified its Regulation A+ (Mini-IPO) offering following a successful September re-launch. BIOLIFE4D has raised more than $3M in equity crowdfunding investments since February of 2018. …
BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart
Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO – September 9, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its…
Recent Blogs
BIOLIFE4D CEO Steven Morris to Speak at Organ Transplant Support Event
As we’ve continued through our journey toward 3D bioprinting a viable heart for human transplant, we’ve been fortunate to receive an incredible outpouring of support from the transplant community. Whether it’s sharing personal transplant stories or advocating for the future of our technology, it can’t be understated how much the community’s support means to us…
Company Update – BIOLIFE4D Filed Recent Patents
We have exciting news to share! Last month, our team took the initiative to protect more of our groundbreaking intellectual property and filed a provisional patent application with the U.S. Patent and Trademark Office. This patent application, #62/962,337, is the second such one that’s been filed over the last year. The other application, #62/845,162, is for…
The Significance of Tomorrow – National Donor Day & Valentine’s Day
Hearts, roses, chocolates, and cards – it’s that time of year again. Tomorrow, we celebrate love and those who mean the most to us. However, Valentine’s Day is not the only national day on our minds. February 14 also marks National Donor Day: a day of awareness dedicated to all types of donation (organ, tissue, eye,…
BIOLIFE4D in the News!
This Company Has Our Hearts – Steven Morris – BIOLIFE4D
Be in the know about BIOLIFE4D and the progress made so far – this is the company that has our hearts! To learn more, CLICK HERE.
BIOLIFE4D CEO Says Firm ‘One Step Closer’ to 3D Printing a Viable Human Heart
By Spencer Feingold | Oct 9 | Cheddar An Illinois-based biomedical technology firm, BIOLIFE4D, reached a watershed moment last month after successfully 3D bioprinting a miniaturized human heart. While not intended for human transplants, the mini heart was a major breakthrough in bioprinting and is expected to have broad implications for pharmaceutical testing. To Read…
A Chicago Biotech Startup’s “Mini-Heart” Could Mean Big Things for 3D Bioprinting
By Steven Ghosett, Sept. 6, 2019 “Our goal is to have this technology available to the people that need it the most and provide a life-saving option for these patients,” he said. “As with any new technology, it should be monitored so it’s not exploited for the wrong purposes.” To reach more, CLICK HERE.
BIOLIFE4D OVERVIEW
PRESS KIT
BIOLIFE4D welcomes the opportunity to speak with the media about bioprinting, its equity crowdfunding raise efforts and how building hearts will save lives.
